Clinical Trials Browser

Pancreatic Neoplasms

NCT00638937 2018-08-29

AZD0530 to Treat Recurrent Stage IIIB/IV NSCLC Previously Treated With Combination Chemotherapy

Phase 2 Completed

37 enrolled 13 charts

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00607594 2018-08-23

Saracatinib in Treating Patients With Locally Advanced or Metastatic Stomach or Gastroesophageal Junction Cancer

Phase 2 Completed

21 enrolled 11 charts

Gastrointestinal

Esophageal Neoplasms, Stomach Neoplasms

NCT00659360 2018-06-29

AZD0530 in Treating Patients With Recurrent Locally Advanced or Metastatic Soft Tissue Sarcoma

Phase 2 Completed

17 enrolled 9 charts

GynecologicSarcoma

Fibrosarcoma, Leiomyosarcoma, Liposarcoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Endometrial Stromal, Dermatofibrosarcoma, Histiocytoma, Malignant Fibrous

NCT00513071 2018-04-19

AZD0530 in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy

Phase 2 Completed

28 enrolled 9 charts

Genitourinary

Prostatic Neoplasms

NCT02085603 2018-04-13

SarCaBon

Phase 2 Completed

12 enrolled

Tumor-Agnostic

Neoplasms

NCT00528645 2017-12-07

AZD0530 in Treating Patients With Extensive Stage Small Cell Lung Cancer

Phase 2 Completed

23 enrolled 7 charts

Thoracic

Pleural Effusion, Malignant, Small Cell Lung Carcinoma

NCT00669019 2014-05-21

Saracatinib in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery

Phase 2 Completed

23 enrolled 6 charts

Dermatologic

Melanoma

NCT00513435 2014-04-30

Saracatinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Phase 2 Completed

9 enrolled 8 charts

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Tongue Neoplasms

NCT00559507 2014-04-30

Saracatinib in Treating Patients With Metastatic or Locally Advanced Breast Cancer That Cannot Be Removed By Surgery

Phase 2 Completed

12 enrolled 8 charts

Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT00558272 2013-05-27

Study to Evaluate the Safety and Effects AZD0530 on Prostate and Breast Cancer Subjects With Metastatic Bone Disease

Phase 2 Completed

139 enrolled 23 charts

BreastGenitourinarySarcoma

Bone Diseases, Bone Neoplasms, Breast Neoplasms, Prostatic Neoplasms

NCT00610714 2012-12-18

OVERT-1

Phase 2 Completed

211 enrolled 12 charts

Gynecologic

Neoplasms, Ovarian Neoplasms

Clinical Trials

Saracatinib in Treating Patients With Previously Treated Metastatic Pancreatic Cancer

AZD0530 to Treat Recurrent Stage IIIB/IV NSCLC Previously Treated With Combination Chemotherapy

Saracatinib in Treating Patients With Locally Advanced or Metastatic Stomach or Gastroesophageal Junction Cancer

AZD0530 in Treating Patients With Recurrent Locally Advanced or Metastatic Soft Tissue Sarcoma

AZD0530 in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy

SarCaBon

AZD0530 in Treating Patients With Extensive Stage Small Cell Lung Cancer

Saracatinib in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery

Saracatinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Saracatinib in Treating Patients With Metastatic or Locally Advanced Breast Cancer That Cannot Be Removed By Surgery

Study to Evaluate the Safety and Effects AZD0530 on Prostate and Breast Cancer Subjects With Metastatic Bone Disease

OVERT-1